![Louis J. Arcudi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Louis J. Arcudi
President at
Millendo Therapeutics US, Inc.
Profile
Louis J.
Arcudi is Co-President & Secretary at Millendo Therapeutics US, Inc. Formerly, Mr. Arcudi was President, Chief Executive Officer & Director at Millendo Therapeutics, Inc. in 2021.
From 2015 to 2018, served as CFO, Treasurer & Chief Accounting Officer at Idera Pharmaceuticals, Inc. From 2002 to 2007, held the position of Treasurer, VP-Administration & Finance at Peptimmune, Inc. Between 2000 and 2003, was Senior Director-Finance & Administration at Genzyme Molecular Oncology.
In 2003, was Senior Director-Finance Business Planning at Genzyme Corp.
Also worked as Controller at Cognex Corp.
Education includes an undergraduate degree from Southern New Hampshire University in 1982 and an MBA from Bryant University in 1987.
Louis J. Arcudi active positions
| Companies | Position | Start |
|---|---|---|
Millendo Therapeutics US, Inc.
 Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | President | - |
Former positions of Louis J. Arcudi
| Companies | Position | End |
|---|---|---|
| MILLENDO THERAPEUTICS | Chief Executive Officer | 2021-06-24 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Director of Finance/CFO | 2018-10-30 |
Peptimmune, Inc.
 Peptimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Director of Finance/CFO | 2007-11-30 |
Genzyme Molecular Oncology
 Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics and diagnostics | Director of Finance/CFO | 2002-12-31 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Director of Finance/CFO | 2002-12-31 |
Training of Louis J. Arcudi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Cognex Corp.
 Cognex Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and markets machine vision computer systems | Electronic Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Health Technology |
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Southern New Hampshire University
 Southern New Hampshire University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Molecular Oncology
Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics and diagnostics | Health Technology |
Bryant University
 Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Louis J. Arcudi
